3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER_GOV
2
OTHER
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
9
Drug Therapy
9
Bevacizumab
9
Radiotherapy
8
Carboplatin
8
Oxaliplatin
7
Cyclophosphamide
7
Surgical Procedures, Operative
6
Cisplatin
6
Capecitabine
6
tislelizumab
5
Paclitaxel
5
Fluorouracil
5
Docetaxel
5
Control Groups
5
Nivolumab
4
Immune Checkpoint Inhibitors
4
Gemcitabine
4
Endoscopic Mucosal Resection
4
sintilimab
3
fludarabine
3
Trastuzumab
3
Pemetrexed
3
Neoadjuvant Therapy
3
Leucovorin
3
Laparoscopy
3
Irinotecan
3
Injections
3
Hematologic Tests
3
HMPL-013
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Etodolac
×
Clear all
NCT06839144
2025-07-11
OC-POP-PT
Tel-Aviv Sourasky Medical Center
Phase 2
Recruiting
60 enrolled
NCT03919461
2019-04-18
COMPIT-2
Assaf-Harofeh Medical Center
Phase 2
Recruiting
200 enrolled